Search

Your search keyword '"Kukreti, Vishal"' showing total 929 results

Search Constraints

Start Over You searched for: Author "Kukreti, Vishal" Remove constraint Author: "Kukreti, Vishal"
929 results on '"Kukreti, Vishal"'

Search Results

4. Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP

16. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

20. Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

23. The I-Can Manage web-based cancer self-management program targeting treatment toxicities and health behaviours: Human centred co-design approach and cognitive-think aloud usability testing (Preprint)

24. Human centered co-design and usability testing of a web-based cancer self-management education program (I-Can Manage) targeting treatment toxicities and health behaviours (Preprint)

25. Chromosome 1q Abnormalities Are Not an Independent Predictor of Survival in Multiple Myeloma

27. Frailty in Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study

28. Correlation Amongst Scoring of Various Frailty Tools in Myeloma Patients Undergoing Autologous Stem Cell Transplantation

29. Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

30. Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

33. Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer

35. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma

36. From Choosing Wisely to Implementing Wisely in Cancer Care: A Scoping Review

37. Five hematologic tests and treatments to question

41. Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume

43. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

44. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

46. Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

49. Outcomes in Relapsed/Refractory Burkitt Lymphoma: A Multi-Centre Canadian Experience

50. Risk Stratification for Relapsed/Refractory Classical Hodgkin Lymphoma Integrating Pretransplant Deauville Score and Residual Metabolic Tumor Volume

Catalog

Books, media, physical & digital resources